VP Pharmaceutical Development & Manufacturing at ORASIS PHARMACEUTICALS - Herzlyia, N/A, IL
Eliminating the need for reading glasses\\Orasis Pharmaceuticals is a privately held pharmaceuticals company, funded by Sequoia Capital. Orasis is engaged in the development of a medical drug for Presbyopia.\\The company was founded by an accomplished team of ophthalmology and optometry researchers, bringing together their knowledge and expertise to develop an innovative ophthalmology pharmaceutical solution for the treatment of Presbyopia symptoms. \Presbyopia is an age-related visual impairment that results from the gradual decrease in accommodation and affect quality of vision and quality of life.\\Orasis's patent-protected innovative solution, CSF-1, is currently in clinical trials, with the aim of improving near uncorrected visual acuity, and ultimately relieving presbyopia symptoms and eliminating the need for reading glasses.\